DIAGNOSTIC DELAY AND CHARACTERIZATION OF THE CLINICAL PRODROME IN AL AMYLOIDOSIS RELATED CARDIOMYOPATHY AMONG 1,173 PATIENTS DIAGNOSED BETWEEN 2001-2018

Prompt recognition and therapy can reverse light chain amyloidosis cardiomyopathy (AL-CM), but diagnosis is commonly delayed. We performed the first population-level study describing the diagnostic delay and clinical prodrome of AL-CM. Using the Optum De-Identified Clinformatics® Datamart